Zusammenfassung
Es ist eine Frage von grundsätzlicher Bedeutung, ob ein Zustand, der dem Patienten keine Beschwerden verursacht, überhaupt behandlungsbedürftig ist. Da diese Frage eng mit der Sicherung der Diagnose der zugrundeliegenden KHK und der Belastung der nachfolgenden Prognose zusammenhängt, soll sie für die unterschiedlichen Typen von Patienten mit stummer Myokardischämie im folgenden getrennt erörtert werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Arnim T von, Selwyn AP, Fox KM (1982) Ischämietypische ST-Senkungen im Langzeit- EKG: Untersuchungen zu Häufigkeit und Variabilität bei ambulanten Patienten. Z Kar- diol 71, Suppl. 2: 602
Arnim T von, Höfling B, Schreiber MA (1985) Characteristics of episodes of ST elevation or ST depression during ambulatory monitoring in patients subsequently undergoing coronary angiography. Br Heart J 54: 484–488
Arnim T von, Höfling B, Schreiber MA (1985) Case-control study of patients with vasospastic angina pectoris. Follow-up over more than 2 years. In: Lichtlen PR (ed) New therapy of ischaemic heart disease and hypertension. Excerpta Medica, Amsterdam Hongkong Princeton Sydney Tokyo, pp 289–296
Arnim T von, Reuschel-Janetschek E, Erath A (1987) Effects of oral nisoldipine on tran-sient and exercise-induced ischemia in patients with coronary heart disease. In: Hugenholtz PG, Meyer J (eds), Nisoldipine 1987. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 288–295
Arnim T von (1987) Influence of Isosorbide-5-Mononitrate 20 mg, sustained-release 50 mg and sustained-release Nifedipine 20 mg on ischemic ST segment changes during holter monitoring. A double-blind cross-over study in patients with spontaneous angina pectoris. Cardiology 74, Suppl. 1: 40–45
Balasubramanian V, Bowles MJ, Khurmi NS, Davies AB, Raftery EB (1982) Evaluation of verapamil and high dose nifedipine in patients with chronic stable angina with objective methods. Acta Med Scand, Suppl. 681: 62–73
Banai S, Stern S, Tzivoni D (1987) Effect of nisoldipine on myocardial ischemia: evaluation by Holter monitoring. In: Hugenholtz PG, Meyer J (eds) Nisoldipine 1987. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 276–281
Cairns JA (1984) Aspirin and sulfinpyrazone in unstable angina. In: Hugenholtz PG, Goldman BS (eds) Unstable angina, current concepts and management. Schattauer, Stuttgart New York, pp 219–227
CASS Principal investigators and their associates. (1983) Coronary artery Surgery Study (CASS): A randomized trial of coronary artery bypass surgery: survival data. Circulation 68: 939
Chierchia S, DeCaterina R, Crea F, et al. (1982) Failure of thromboxane A, blockade to prevent attacks of vasospastic angina. Circulation 66: 702–705
Chierchia S, Glazier JJ, Gerosa S (1987) A single-blind, placebo-controlled study of effects of atenolol on transient ischemia in „mixed” Angina. Am J Cardiol 60: 36A–40A
Cohn PF (1985) Silent myocardial ischemia as a manifestation of asymptomatic coronary artery disease: what is appropriate therapy? Am J Cardiol 56: 28D–34D
Deanfield JF, Maseri A, Selwyn AP, Ribeiro P, Chierchia S, Krikler S, Morgan M (1983) Myocardial ischemia during daily life in patients with stable angina: its relation to symp-toms and heart rate changes. Lancet II: 753–758
Deanfield JE, Spiegelhalter D (1987) Variability of myocardial ischemia in chronic stable angina. In: Arnim T von, Maseri A (eds) Silent ischemia, current concepts and manage-ment. Steinkopff, Darmstadt, Springer, New York, pp 203–207
Diamond GA (1987) The silent treatment. Am J Cardiol 60: 1170–1172
Distante A, Maseri A, Severi S (1979) Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate: a double-crossover study in a coronary care unit. Am J Cardiol 44: 533–539
Fazzini PF, Multino D, Zambaldi G (1985) Diltiazem in spontaneous angina: double blind cross over study with Holter monitoring. G Ital Cardiol 15: 1085–1089
Finci L, Meier B, Steffino G, Righetti A, Bodenmann JJ, Rutishauser W (1987) Coronary angioplasty in silent myocardial ischemia. In: Arnim T von, Maseri A (eds) Silent ische-mia, current concepts and managememt. Steinkopff, Darmstadt, Springer, New York, pp 162–169
Findlay JN, MacLeod K, Gillen G, Elliott AT, Aitchison T, Dargie HJ (1987) A double- blind placebo controlled comparison of verapamil, atenolol and their combination in patients with chronic stable angina pectoris. Br Heart J 57: 336–343
FitzGibbon GM, Burton JR, Keon WJ (1984) Aortocoronary bypass surgery in „asymptomatic” patients with coronary artery disease. In: Rutishauser W, Roskamm H (eds) Silent myocardial ischemia. Springer, Berlin Heidelberg New York Tokyo, pp 180–193
Fox KM, Jonathan A, Selwyn AP (1982) Effects of platelet inhibition on myocardial ische-mia. Lancet II: 727–730
Frishman WH, Teicher M (1987) Antianginal drug therapy for silent myocardial ischemia. Am Heart J 114: 140–147
Glasser SP, Arce-Weston B, Clark PI (1987) Improvement in silent myocardial ischemia with nisoldipine. In: Hugenholtz PG, Meyer J (eds) Nisoldipine 1987. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 296–298
Gottlieb SO, Weisfeldt ML, Ouyang P, Achuff SC, Baughman KL, Trail TA, Brinker JA, Shapiro EP, Chandra NC, Mellits ED, Townsend SN, Gerstenblith G (1986) Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a rando-mized, double-blind, placebo-controlled trial. Circulation 73: 331–337
Grodin CM, Kretz JG, Vouhe P, Tubau JF, Compeau L, Bourassa MG (1978) Prophylactic coronary artery grafting in patients with few or no symptoms. Ann Thorac Surg 28: 113
Hammermeister KE, DeRouen TA, Dodge HT (1980) Effect of coronary surgery on survival in asymptomatic and minimally symptomatic patients. Circulation 62: 98
Hausmann D, Nikutta P., Hartwig CA, Daniel WG, Lichtlen PR (1987) ST-Segment-Analyse im 24-Stunden-Langzeit-EKG bei Patienten mit stabiler Angina pectoris und angiographisch nachgewiesener Koronarsklerose. Z Kardiol 76: 554–562
Imperi GA, Lambert CR, Coy K, Lopez L, Pepine CJ, Shepard C (1987) Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol 60: 519–524
Johnson SM, Mauritson DR, Willerson JT, Hillis LD (1981) A controlled trial of verapamil for Prinzmetal’s variant angina. New Engl J Med 304: 862–866
Kent KM, Rosing DR, Ewels CJ, Kipson L, Bonow R, Epstein SE (1982) Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease. Am J Cardiol 49: 1823–1829
Khurmi NS, Bowles MJ, O’Hara MJ, Raftery EB (1986) Effect of propranolol in indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST-segment monitoring. Clin Cardiol 9: 391–397
Levin RI, Keller B, Campbell DQ (1986) Long-term ambulatory ECG monitoring for opti-mizing anti-ischemic therapy. Circulation 74, Suppl. II: 190
Lewis HD, Davies JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. New Engl J Med 309: 396–403
Mathes P (ed) (1985) Secondary prevention in coronary artery disease and myocardial infarction. Martinus Nijhoff, Boston The Hague Dordrecht Lancaster
Meinertz T, Zehender M, Just H (1987) Calcium antagonists in silent myocardial ischemia-preliminary results with nisoldipine. In: Hugenholtz PG, Meyer J (eds), Nisoldipine 1987. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 282–287
Multiple Risk Factor Intervention Trial Research Group (1985) Exercise electrocardiogram and coronary heart disease mortality in the multiple risk factor intervention trial. Am J Cardiol 55: 16–24
Nademanee K, Intarachot V, Robertson HA, Mody V, Singh BN (1987) Variability of parameters of myocardial ischemia: a comparison of exercise treadmill test, ambulatory ECG monitoring and symptoms of myocardial ischemia. Circulation 76, Suppl. IV: 390
Nager F (1987) Medikamentöse Therapie der stabilen Angina pectoris. Internist 28: 721–726
Parodi O, Simonetti I, Michelassi C, Carpeggiani C, Biagini A, L’Abbate A, Maseri A (1986) Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit. Am J Cardiol 57: 899–906
Passamani E, Davis KB, Gillespie MJ, Killip T, and the CASS principal invesigators and their associates (1985) A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. New Engl J Med 312: 1665–1672
Pepine CJ, Imperi GA, Hill JA (1987) Therapeutic implications of silent myocardial ische-mia during daily activity. Am J Cardiol 59: 993–995
Previtali M, Panciroli C, Ardissino D, Chimienti M, Angoli L, Salerno JA (1987) Spontaneous remission of variant angina documented by Holter monitoring and ergonovine testing in patients treated with calcium antagonists. Am J Cardiol 59: 235–240
Quyyumi AA, Crake T, Wright CM, Mockus LJ, Fox KF (1987) Medical treatment of pati-ents with severe exertional and rest angina: double blind comparison of p-blocker, calcium antagonist and nitrate. Br Heart J 57: 505–511
Reznekov L (1985) Silent myocardial ischemia: therapeutic implications. Am J Med 79, Suppl.3 A: 30–34
Rizzon P, Scrutinio D, Mangini G, Lagioia R, deToma L (1986) Randomized placebo-controlled comparative study of nifedipine, verapamil and isosorbide dinitrate in the treatment of angina at rest. Eur Heart J 7: 67–76
Robertson RM, Wood AJ, Bernard Y (1981) Exacerbation of ischemia in vasotonic angina pectoris by propranolol. Am J Cardiol 47: 463–471
Rutishauser W, Roskamm H (1985) Silent myocardial ischemia, Springer, Berlin Heidelberg New York Tokyo.
Schang SJ, Pepine CJ (1977) Transient asymptomatic ST-segment depressing during daily activity. Am J Cardiol 39: 396–402
Shell WE (1985) Mechanisms and therapy of silent myocardial ischemia and the effect of transdermal nitroglycerin. Am J Cardiol 56: 231–271
Stone PH (1987) Calcium antagonists for Prinzmetal’s variant angina, unstable angina and silent myocardial ischemia: Therapeutic tool and probe for identification of pathophysiologic mechanisms. Am J Cardiol 59: 101B–115B
Thurer RL, Lytle BW, Cosgrove DM, Loop FD (1976) Asymptomatic coronary artery disease managed by myocardial revascularization: results at 5 years. Circulation 61, Suppl.l: 1–14
Tzivoni D, Keren A, Gavish A, Benhorin J, Stern S (1987) Guiding anti-ischemic therapy by Holter monitoring. In: Arnim T von, Maseri A (eds) Silent ischemia, current concepts and managememt. Steinkopff, Darmstadt, Springer New York, pp 177–183
Winniford MD, Johnson SM, Mauritson DR, Rellase JS, Redish GA, Willerson JT, Hillis D (1982) Verapamil therapy for Prinzmetal’s variant angina: comparison with placebo and nifedipine. Am J Cardiol 47: 33–38
Winniford MD, Gabliani G, Johnson SM, Mauritson DR, Fultom KL, Hillis LD (1984) Concomitant calcium antagonist plus isosorbide dinitrate therapy for markedly active vari-ant angina. Am Heart J 108: 1269–1273
World Health Organization European Collaborative Group (1986) European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. Lancet, Saturday 19 April 1986: 869–872
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
von Arnim, T. (1988). Therapie. In: Die stumme Myokardischämie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73568-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-73568-4_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73569-1
Online ISBN: 978-3-642-73568-4
eBook Packages: Springer Book Archive